Data sheet
Benchling for antibody therapeutics R&D
Antibodies are an important class of therapeutic agents which have evolved significantly over the past 30 years. Antibody R&D is now more streamlined than ever, but several factors continue to contribute to its complexity.
This data sheet discusses:
The complexities faced during both research and discovery phases
Why current solutions fail to meet these needs
How Benchling’s capabilities have helped address these challenges for leading antibody companies
View data sheet
Join over 200,000 scientists using Benchling to power their biotech R&D
